Home - Australian Pharmacist

TEST: 5 ways patients judge your professionalism

Deanna Mill MPS - January 12, 2000

Industry

Preparing for the 2024 ‘tripledemic’

Chloe Hava - February 1, 2000

Industry

Now is the time to arm Australians with vaccines, respiratory disease advice, testing and essential medicines to get ahead of respiratory ailment season. The trifecta...

A thiazolidinedione for hepatitis B

Dr Esther Lau and Prof Lisa Nissen - January 28, 2000

Clinical

Thiazolidinediones may hold the key to developing a new class of anti-HBV medicines that will cure the chronic infection.

Maria Berbecaru extended interview

Ruth Cooper - June 17, 2000

Industry

Just 3 years out of university, in 2019 Maria Berbecaru MPS made history by implementing Australia's first integrated community pharmacy-delivered medicine supply and on-site...

Waiting to inhale

Dr Leigh Dayton - June 20, 2000

Clinical

Annoyed by her glass squeeze-bulb nebuliser, 13-year old asthmatic Susie Maison asked "Daddy why can't they put my asthma medicine in a spray can?"

Oral Antihyperglycaemics for COPD exacerbations

A/Prof Esther Lau and Prof Lisa Nissen - May 9, 2000

Clinical

Emerging evidence is pointing to the benefits of ‘novel’ antihyperglycaemics on lung function in COPD patients.

1...294295296...302 Page 295 of 302

Tell us about your journey to becoming a prescribing pharmacist.

Are you offering expanded services in your pharmacies?

What impact has this had on patients and staff?

What would you say to pharmacists apprehensive about prescribing?

Which aspect of scope of practice expansion excites you the most?

What services are you keen to see pharmacists branch into?

Where do you see scope of practice going nationally?

What scope of practice sessions or panels are you excited to see at PSA25?

Why is it important to connect with other pharmacists at industry events like PSA25?

What happens if a pharmacy sends a token to the wrong phone number?

What can cause the token to be associated with the wrong phone number?

Will correcting the number and reissuing the token ‘fix everything’?

Then what should I do?

Do I need to report this to my indemnity insurer?

How can this be avoided?

References

Booming business, bad practice

A real danger for patients

Your professional obligations

Time for a change

Why does endometriosis take so long to diagnose?

When should endometriosis be suspected?

What’s the role of pharmacists?

What are the treatment options?

What does the future hold?

What key changes are introduced in the updated standards?

What previously met the standards but now breaches them?

How can I comply with the new standards?

Do the changes apply to both prescription and Pharmacist Only vapes?

Can I sell my existing products until the stock is exhausted?

Do the new standards mean vapes are now first-line therapy?

Is there a first-line therapy specifically for vaping cessation?

Tell us about your journey to becoming a prescribing pharmacist.

Are you offering expanded services in your pharmacies?

What impact has this had on patients and staff?

What would you say to pharmacists apprehensive about prescribing?

Which aspect of scope of practice expansion excites you the most?

What services are you keen to see pharmacists branch into?

Where do you see scope of practice going nationally?

What scope of practice sessions or panels are you excited to see at PSA25?

Why is it important to connect with other pharmacists at industry events like PSA25?

What happens if a pharmacy sends a token to the wrong phone number?

What can cause the token to be associated with the wrong phone number?

Will correcting the number and reissuing the token ‘fix everything’?

Then what should I do?

Do I need to report this to my indemnity insurer?

How can this be avoided?

References

Booming business, bad practice

A real danger for patients

Your professional obligations

Time for a change

Why does endometriosis take so long to diagnose?

When should endometriosis be suspected?

What’s the role of pharmacists?

What are the treatment options?

What does the future hold?

What key changes are introduced in the updated standards?

What previously met the standards but now breaches them?

How can I comply with the new standards?

Do the changes apply to both prescription and Pharmacist Only vapes?

Can I sell my existing products until the stock is exhausted?

Do the new standards mean vapes are now first-line therapy?

Is there a first-line therapy specifically for vaping cessation?

Tell us about your journey to becoming a prescribing pharmacist.

Are you offering expanded services in your pharmacies?

What impact has this had on patients and staff?

What would you say to pharmacists apprehensive about prescribing?

Which aspect of scope of practice expansion excites you the most?

What services are you keen to see pharmacists branch into?

Where do you see scope of practice going nationally?

What scope of practice sessions or panels are you excited to see at PSA25?

Why is it important to connect with other pharmacists at industry events like PSA25?

What happens if a pharmacy sends a token to the wrong phone number?

What can cause the token to be associated with the wrong phone number?

Will correcting the number and reissuing the token ‘fix everything’?

Then what should I do?

Do I need to report this to my indemnity insurer?

How can this be avoided?

References